Novartis halts Pluvicto new patient starts, struggles with radiotherapy’s supply amid manufacturing expansion aliu Tue, 02/28/2023 – 14:18 More: Novartis halts Pluvicto new patient starts, struggles with radiotherapy's supply amid manufacturing expansion Source: fierce
read moreBayer grapples with Eylea sales slowdown, sees trend continuing in 2023 kdunleavy Tue, 02/28/2023 – 11:14 More: Bayer grapples with Eylea sales slowdown, sees trend continuing in 2023 Source: fierce
read moreBig-sellers from Merck, Novo and Lilly likely to face Medicare price negotiations: report fkansteiner Tue, 02/28/2023 – 11:05 More: Big-sellers from Merck, Novo and Lilly likely to face Medicare price negotiations: report Source: fierce
read moreA Kafka-esque transformation and the story of MS through ‘The Metamorphosis’: book review badams Tue, 02/28/2023 – 09:54 More: A Kafka-esque transformation and the story of MS through 'The Metamorphosis': book review Source: fierce
read moreMerck ends last Keytruda trial in aggressive prostate cancer campaign, takes separate hit in lung cancer aliu Tue, 02/28/2023 – 09:40 More: Merck ends last Keytruda trial in aggressive prostate cancer campaign, takes separate hit in lung cancer Source: fierce
read moreResearch into modified RNA messages could help treat diseases and develop new therapies More: Hope for Parkinson’s disease and Lewy body dementia patients Source: News
read more© 1994 - 2023 B.M. Pharmaceuticals